ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Proposed Models for Prediction of Mortality in Stage-I and Stage-II Gastric Cancer and 5 Years after Radical Gastrectomy

Fang, Tianyi; Yin, Xin; Wang, Yufei; Zhang, Lei; Zhang, Xinghai; Zhao, Xudong; Wang, Yimin; Xue, Yingwei*哈尔滨医科大学
Journal of Oncology2022-3-8DOI: 10.1155/2022/4510000
6被引10阅读
引用收藏
分享

摘要

The current American Joint Committee on Cancer (AJCC) staging system provides limited information for patients with early death from stage-I and stage-II gastric cancer (GC) and death at > 5 years after radical gastrectomy. The aim of this study was to construct nomogram models to predict the mortality risk of these patients. In this study, clinical and pathological data on patients who underwent curative gastrectomy at Harbin Medical University Cancer Hospital between 2000 and 2014 were retrospectively collected. Receiver operating characteristic analysis was used to screen for sensitive serum immune biomarkers to predict the risk of mortality death > 5 years after radical gastrectomy (Group A) and risk of early death in stage-I and stage-II GC (Group B). The prediction model was constructed by combining serum immune markers with clinicopathological features by R Studio. We found that serum fibrinogen (F), systemic immune inflammation (SII), and pTNM stage were independent risk factors for prognosis in Group A (P < 0.05). F, SII, age, Borrmann type, and scope of gastrectomy were independent risk factors for prognosis in Group B (P < 0.05). The area under the curve of the predictive model in Groups A and B was 0.726 and 0.848, respectively. In conclusion, the predictive models of F and SII combined with clinicopathological features can predict high mortality risk in patients with stage-I and stage-II GC and > 5 years after radical gastrectomy, which will contribute to the supplement of the traditional AJCC system and to individual survival prediction.

学科与关键词

关键词
TUMOR-CELLSLARGE-SCALEMECHANISMSFIBRINOGENRECURRENCERESECTIONSURVIVALTHERAPY
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-03-08
卷期
第 2022 卷
页码
4510000
DOI
10.1155/2022/4510000
期刊等级
4区
成果收录
SCIE
资助标注
Nn10 program of Harbin Medical University Cancer Hospital [Nn10 PY 2017-03]; Haiyan Research Fund of Harbin Medical University Cancer Hospital from Tianyi Fang [JJQN2021-06]

作者

  • F

    Fang, Tianyi (第一作者)

    harbin med univ

  • Y

    Yin, Xin

    harbin med univ

查看全部 8 位作者收起作者
  • W

    Wang, Yufei

    harbin med univ

  • Z

    Zhang, Lei

    harbin med univ

  • Z

    Zhang, Xinghai

    harbin med univ

  • Z

    Zhao, Xudong

    harbin med univ

  • W

    Wang, Yimin

    harbin med univ

  • X

    Xue, Yingwei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417